Camptothecin-psammaplin A hybrids as topoisomerase I and HDAC dual-action inhibitors.

MLA

Cincinelli, Raffaella, et al. “Camptothecin-Psammaplin A Hybrids as Topoisomerase I and HDAC Dual-Action Inhibitors.” European Journal of Medicinal Chemistry, vol. 143, Jan. 2018, pp. 2005–14. EBSCOhost, https://doi.org/10.1016/j.ejmech.2017.11.021.

APA

Cincinelli, R., Musso, L., Artali, R., Guglielmi, M., Bianchino, E., Cardile, F., Colelli, F., Pisano, C., & Dallavalle, S. (2018). Camptothecin-psammaplin A hybrids as topoisomerase I and HDAC dual-action inhibitors. European Journal of Medicinal Chemistry, 143, 2005–2014. https://doi.org/10.1016/j.ejmech.2017.11.021

Chicago

Cincinelli, Raffaella, Loana Musso, Roberto Artali, Mario Guglielmi, Erminia Bianchino, Francesco Cardile, Fabiana Colelli, Claudio Pisano, and Sabrina Dallavalle. 2018. “Camptothecin-Psammaplin A Hybrids as Topoisomerase I and HDAC Dual-Action Inhibitors.” European Journal of Medicinal Chemistry 143 (January): 2005–14. doi:10.1016/j.ejmech.2017.11.021.